Bruker Corp at Jefferies Healthcare Conference (Virtual) Transcript
Hey, good morning. Welcome to the Jefferies 2020 Virtual Global Healthcare Conference. I'm Brandon Couillard, Senior Life Science Tools and Diagnostics Analyst here at the firm.
Here I'm happy to have Bruker with us back at the conference this year. From the company, we've got Chairman, CEO, Dr. Frank Laukien; as well as Juergen Srega, who heads Bruker's CALID unit.
I'll turn it over to frank to make a few opening remarks before jumping into Q&A. (Operator Instructions)
Frank, thanks for being here.
Thank you, Brandon. It's great to be at the Jefferies healthcare conference again and again with Juergen in ASMS week, although this year, of course, it's a virtual ASMS 2020 reboot, as they call it.
As you will have seen from our press release that we issued for -- with our product launches for ASMS, I think we have -- we can be very pleased with our R&D productivity and the new
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |